Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Rewriting the fate of advanced cancers. Send enquiries to [email protected].

News

News menafn 4 years ago
Epiaxis Therapeutics Announces Positive Clinical Trial Data For Its New Drug Program To Inhibit Metastatic Breast Cancer
Epiaxis Therapeutics Announces Positive Clinical Trial Data For Its New Drug Program To Inhibit Metastatic Breast Cancer. EpiAxis Therapeutics is based in Sydney, Australia.EpiAxis Therapeutics has announced a pioneering clinical study, showing that an ep
Read more
Report